TRIAL DETAIL
An Open Label Treatment Extension Study of AMG 706
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
An Open Label Treatment Extension Study of AMG 706 |
|||
NCT#: |
||||
Conditions: |
Solid Tumors |
|||
Status: |
Ongoing, but not recruiting |
|||
Phase: |
2 |
Start Date 12/01/2005 |
Age of Trial (yrs) 18.4 |
|
Treatment Phase: |
Extension Study |
|||
Drug Category: |
KIT/PDGFRA inhibitor
VEGFR inhibitor (TKI) |
|||
Strategy: |
Block KIT |
|||
Trial Type: |
GIST not specified. GIST patient enrollment unknown. |
|||
Other Protocol IDs: |
20050130 |
|||
Sponsor: |
Amgen Inc. |
|||
Patient Contact: |
Amgen Call Center |
|||
Contact email: |
||||
Contact Phone: |
866-572-6436 |
|||
Randomized: |
||||
IV or Oral: |
Oral |
|||
Trial Notes: |
This is an extension study to provide ongoing treatment with AMG 706 monotherapy for subjects with solid tumors who have completed the planned duration of treatment with AMG 706 on a previous/separate Amgen protocol and demonstrated continuing clinical benefit. |
|||
Trial Links |
Trial Results |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |